A legacy Research Base serving the CCOP program since 1983, transitioning into NCORP, the University of Rochester (URCC) proposes to continue its research focus on decreasing physical and psychological treatment-related morbidity and mortality among cancer patients, survivors, and their care partners by improving the quality of cancer care that addresses toxicities and side effects stemming from the cancer experience. Over the past 30 years the URCC has evolved and developed considerable resources for cancer control and cancer care delivery research activities. The 4,871 credits earned during the last five-year renewal period by Research Base affiliates on URCC protocols are 22% of the total cancer control credits provided for the 14 research bases funded during that period, according to NCI CCOP Program Staff. Over the next five years, the Research Base will continue its commitment as a university-based NCORP Research Base, producing state-of-the-science cancer control and cancer care delivery research. Our process and organization fosters protocol development through close collaboration among community affiliates and experienced investigators; data collected through our clinical and observational trials informs future research and policy; we pioneer use of new methodologies and exploration of mechanistic pathways; and we are dedicated to increasing the diversity of participants in our trials and to training junior investigators and community affiliates. Fifty-seven different potential research concepts have been presented and discussed in open forum at the last five annual group meetings. Twenty-one of them were proposed by colleagues geographically outside the University including eight from community affiliates. Each of the current eight approved protocols is either chaired or co-chaired by current CCOP/MBCCOP community affiliates.

Public Health Relevance

Symptoms and side effects of cancer and its treatment can significantly affect patients' well-being and are frequently dose-limiting factors in potentially curative treatments. Dr. Harold Varmus recognized the relevance and benefits of their control when he said 'Cancer Patients are living longer and better lives, thanks to better symptom control, more effective therapies, and a deeper understanding of cancer'.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Research Cooperative Agreements - Single Project (UG1)
Project #
5UG1CA189961-03
Application #
9117487
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
O'Mara, Ann M
Project Start
2014-08-01
Project End
2019-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Rochester
Department
Surgery
Type
School of Medicine & Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Janelsins, Michelle C; Heckler, Charles E; Peppone, Luke J et al. (2018) Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. J Clin Oncol :JCO2018786624
Dunne, Richard F; Roussel, Breton; Culakova, Eva et al. (2018) Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol :
Palesh, Oxana; Scheiber, Caroline; Kesler, Shelli et al. (2018) Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial. Br J Cancer 119:274-281
Gewandter, Jennifer S; Chaudari, Jenna; Ibegbu, Chinazom et al. (2018) Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study. Support Care Cancer :
Mohile, Supriya G; Dale, William; Somerfield, Mark R et al. (2018) Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol 36:2326-2347
Williams, AnnaLynn M; Shah, Raven; Shayne, Michelle et al. (2018) Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. J Neuroimmunol 314:17-23
Kleckner, Ian R; Jones, Rebecca M; Wilder-Smith, Oliver et al. (2018) Simple, Transparent, and Flexible Automated Quality Assessment Procedures for Ambulatory Electrodermal Activity Data. IEEE Trans Biomed Eng 65:1460-1467
Palesh, Oxana; Kamen, Charles; Sharp, Susan et al. (2018) Physical Activity and Survival in Women With Advanced Breast Cancer. Cancer Nurs 41:E31-E38
Mohile, Supriya G; Magnuson, Allison; Pandya, Chintan et al. (2018) Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer. J Natl Compr Canc Netw 16:301-309
Loh, Kah Poh; McHugh, Colin; Mohile, Supriya G et al. (2018) Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients. Curr Oncol Rep 20:25

Showing the most recent 10 out of 106 publications